Federico Dajas-Bailador

Dr. Federico Dajas-Bailador

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2012 in Nature Neuroscience
Verified
Journal Article
Closed access
FDFederico Dajas-Bailador
Federico Dajas-Bailador
BBBoyan Bonev
Boyan Bonev
PGPatricia Pestana Garcez
Patricia Pestana Garcez
PSPeter Stanley
Peter Stanley
FGFrancois Guillemot
Francois Guillemot
NPNancy Papalopulu
Nancy Papalopulu



29 April 2002 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
FDFederico Dajas-Bailador
Federico Dajas-Bailador
AMAdrian J. Mogg
Adrian J. Mogg
SWSusan Wonnacott
Susan Wonnacott
Neuronal nicotinic acetylcholine receptors (nAChR) can regulate several neuronal processes through Ca2+‐dependent mechanisms. The versatility of nAChR‐mediated responses presumably reflects the spatial and temporal characteristics of local changes in intracellular Ca2+ arising from a variety of sources. The aim of this study was to analyse the components of nicotine‐evoked Ca2+ signals in SH‐SY5Y cells, by monitoring fluorescence changes in cells loaded with fluo‐3 AM. Nicotine (30 µm) generated a rapid elevation in cytoplasmic Ca2+ that was partially and additively inhibited (40%) by α7 and α3β2* nAChR subtype selective antagonists; α3β4* nAChR probably account for the remaining response (60%). A substantial blockade (80%) by CdCl2 (100 µm) indicates that voltage‐operated Ca2+ channels (VOCC) mediate most of the nicotine‐evoked response, although the α7 selective antagonist α‐bungarotoxin (40 nm) further decreased the CdCl2‐ resistant component. The elevation of intracellular Ca2+ levels provoked by nicotine was sustained for at least 10 min and required the persistent activation of nAChR throughout the response. Intracellular Ca2+ stores were implicated in both the initial and sustained nicotine‐evoked Ca2+ responses, by the blockade observed after ryanodine (30 µm) and the inositoltriphosphate (IP3)‐receptor antagonist, xestospongin‐c (10 µm). Thus, nAChR subtypes are differentially coupled to specific sources of Ca2+: activation of nAChR induces a sustained elevation of intracellular Ca2+ levels which is highly dependent on the activation of VOCC, and also involves Ca2+ release from ryanodine and IP3‐dependent intracellular stores. Moreover, the α7, but not α3β2* nAChR, are responsible for a fraction of the VOCC‐independent nicotine‐evoked Ca2+ increase that appears to be functionally coupled to ryanodine sensitive Ca2+ stores.

15 July 2009 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
NSNatalia Sanchez-Soriano
Natalia Sanchez-Soriano
MTMark Travis
Mark Travis
FDFederico Dajas-Bailador
Federico Dajas-Bailador
CGCatarina Gonçalves-Pimentel
Catarina Gonçalves-Pimentel
AWAlan J. Whitmarsh
Alan J. Whitmarsh
APAndreas Prokop
Andreas Prokop
Spectraplakins are large actin-microtubule linker molecules implicated in various processes, including gastrulation, wound healing, skin blistering and neuronal degeneration. Expression data for the mammalian spectraplakin ACF7 and genetic analyses of the Drosophila spectraplakin Short stop (Shot) suggest an important role during neurogenesis. Using three parallel neuronal culture systems we demonstrate that, like Shot, ACF7 is essential for axon extension and describe, for the first time, their subcellular functions during axonal growth. Firstly, both ACF7 and Shot regulate the organisation of neuronal microtubules, a role dependent on both the F-actin- and microtubule-binding domains. This role in microtubule organisation is probably the key mechanism underlying the roles of Shot and ACF7 in growth cone advance. Secondly, we found a novel role for ACF7 and Shot in regulating the actin cytoskeleton through their ability to control the formation of filopodia. This function in F-actin regulation requires EF-hand motifs and interaction with the translational regulator Krasavietz/eIF5C, indicating that the underlying mechanisms are completely different from those used to control microtubules. Our data provide the basis for the first mechanistic explanation for the role of Shot and ACF7 in the developing nervous system and demonstrate their ability to coordinate the organisation of both actin and microtubule networks during axonal growth.

15 November 2019 in Neurobiology of Disease
Verified
Journal Article
Open access
ALAndrea Loreto
Andrea Loreto
CHCiaran S. Hill
Ciaran S. Hill
VHVictoria L. Hewitt
Victoria L. Hewitt
Giuseppe OrsomandoGiuseppe Orsomando
Giuseppe Orsomando
CACarlo Angeletti
Carlo Angeletti
MCMichael P. Coleman
Michael P. Coleman
Wallerian degeneration of physically injured axons involves a well-defined molecular pathway linking loss of axonal survival factor NMNAT2 to activation of pro-degenerative protein SARM1. Manipulating the pathway through these proteins led to the identification of non-axotomy insults causing axon degeneration by a Wallerian-like mechanism, including several involving mitochondrial impairment. Mitochondrial dysfunction is heavily implicated in Parkinson's disease, Charcot-Marie-Tooth disease, hereditary spastic paraplegia and other axonal disorders. However, whether and how mitochondrial impairment activates Wallerian degeneration has remained unclear. Here, we show that disruption of mitochondrial membrane potential leads to axonal NMNAT2 depletion in mouse sympathetic neurons, increasing the substrate-to-product ratio (NMN/NAD) of this NAD-synthesising enzyme, a metabolic fingerprint of Wallerian degeneration. The mechanism appears to involve both impaired NMNAT2 synthesis and reduced axonal transport. Expression of WLDS and Sarm1 deletion both protect axons after mitochondrial uncoupling. Blocking the pathway also confers neuroprotection and increases the lifespan of flies with Pink1 loss-of-function mutation, which causes severe mitochondrial defects. These data indicate that mitochondrial impairment replicates all the major steps of Wallerian degeneration, placing it upstream of NMNAT2 loss, with the potential to contribute to axon pathology in mitochondrial disorders.